Biocurious: Alterity “off to the races” in quest for Motor System Atrophy cure

The developer of a drug for the rare motor system atrophy, Alterity is poised to launch a pivotal phase III trial after productive chats with the US Food and Drug Administration.

Rise and Shine: Everything you need to know before the ASX opens

Good morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today.

Brownfields Revival: ASX companies turning back the clock for faster path to production

A growing number of ASX companies are targeting brownfields opportunities in proven mining districts to reduce risk and fast-track the path to production.

Stockhead Long Shortz: Australian Oil Company dives into Surat Basin development

Tylah Tully catches up with AOK MD Kane Marshall to go over the development initiatives and enticing exploration targets across its Surat Basin portfolio.

Long Shortz with Aroa Biosurgery: Symphony remains well positioned under CMS proposal

Aroa's Brian Ward and Zack Bridges unpack the proposed CMS reimbursement update and what it means for Symphony.

Protecting investment portfolio in a volatile new era